Companies drag J&K and central government to court over rolling back tax sops

Mumbai: About 50 FMCG and pharmaceutical companies that were given tax exemptions for investing in industrially marginal areas of J&K, have dragged the state and central government to court over the apparent lack of such concessions in the Goods and Services Tax (GST).

Under the erstwhile tax regime, manufacturers who would invest in some areas would get indirect tax exemptions from the state governments – and sometimes from the central government. The idea was to encourage more investments in these exempted zones.

The companies claimed that they had invested in the state based on promises made under the earlier tax regime. The benefits were withdrawn after July 1, 2017, as all the indirect taxes were subsumed in GST.

The Jammu High Court on Friday issued notices to the governments and the GST council for clarity on the matter.

“The unintended omission of continuing tax benefits has virtually rendered doing business in these areas economically unviable,” said Abhishek A Rastogi, partner at Khaitan & Co, who is also the lawyer for some of the companies.

Post implementation of GST, they are facing considerable financial hardship as erstwhile excise exemptions have been short-changed for central and State budgetary support schemes with only 29% of IGST refund for inter-state supplies, said Rastogi.

Some of the companies claimed that the tax sops for them could have continued till 2017 had it not been for GST.

While J&K government has been giving 100% refund of the taxes to be paid in the state there has been a significant reduction to tax sops from the centre.

The main difference between the erstwhile tax regime and GST is that the latter is a consumption based taxation. Which would mean that GST paid where the consumption happens. Due to which many states that were offering tax sops for setting up units and attracting investments would now not collect as much taxes. The GST would be collected in states where the consumer resides or where actual consumption takes place.

This has led to a problem for a lot of states that had dished out tax sops to attract investment earlier. Many companies in other states like Uttrakhand, J&K, Himachal Pradesh and the North East too have dragged the government to court and filed writ petitions.

  • Related Posts

    Antibiotic Misuse Among 62% Of Mumbaikars Sparks AMR Warnings: Survey

    Mumbai:  India has one of the highest infectious disease burdens in the world. Consumption of antibiotics is widespread and often self-regulated, which leads to a rise in Antimicrobial Resistance (AMR).…

    1680 Onerex Cough Syrup Bottles Loaded In A Luxury Car Seized, One Arrested

    Satna: Amarpatan police station has seized a huge consignment of intoxicating cough syrup on Katni-Bela National Highway. Police have also arrested a youth after seizing cough syrup and a car…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Healthcare, pharma sectors raise Rs 14,811 crore via IPOs in 2024

    Healthcare, pharma sectors raise Rs 14,811 crore via IPOs in 2024

    NPPA sets retail prices for 65 drugs, revises ceiling for 20 formulations

    NPPA sets retail prices for 65 drugs, revises ceiling for 20 formulations

    India-Latin America trade and collaboration prospects discussed at Kerala University conference

    India-Latin America trade and collaboration prospects discussed at Kerala University conference

    Karnataka Govt Files Criminal Cases Against Pharma Firm In Ballari Maternal Deaths Case

    Karnataka Govt Files Criminal Cases Against Pharma Firm In Ballari Maternal Deaths Case

    NPPA Notifies Ceiling Price Of 13 Formulations, Retail Price Of 65 New Drugs

    NPPA Notifies Ceiling Price Of 13 Formulations, Retail Price Of 65 New Drugs

    Over 14,000 PMBJK Centres Set Up To Provide Generic Medicines: Govt

    Over 14,000 PMBJK Centres Set Up To Provide Generic Medicines: Govt